| Sources | Names Used |
|---|---|
| GDSC1000 | BAY 61-3606 |
| PharmacoGx | BAY 61-3606 |
| Database | Identifier |
|---|---|
| Pubchem: | 10200390 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDE6G | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | TANGO2 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | MARCH7 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | DRAM2 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | CTB-50L17.10 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CANT1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | CRADD | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | YY1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | UBE2Q2 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | CDKN1A | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
